from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2577/-

LFCtreatmentdescriptionclass of inhibitor

0.020

Amikacinug/mL Amikacintranslation

0.823

Cap5-10ug/mL Capreomycintranslation

-0.330

Rox10-50 ug/mL Roxithromycintranslation

-0.627

SM2-5 ug/mL Streptomycintranslation

0.050

Tet5-10 ug/mL Tetracyclinetranslation

0.067

Rif0.2-5ug/mL Rifampicintranscription

0.507

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.608

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.330

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.572

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.389

Clofazimine10-13 ug/mL Clofaziminerespiration

0.428

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.821

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.295

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.276

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.128

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.806

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.566

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.766

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.196

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.409

Nigericin50 uM Nigericinrespiration

0.075

TRC10-150 ug/mL Triclosanrespiration

0.389

TRZ10-25 ug/mL Thioridazinerespiration

0.476

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.628

menadione6-10 ug/mL Menadionerespiration

0.246

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.243

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.176

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.223

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.548

NRP_1Non-replicating persistence stage 1dosRassociated

0.538

Amp0.2mg/mL AmpicillincellWall

-0.141

Cephalexin20-100 ug/mL CephalexincellWall

0.904

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.177

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.511

EMB10-20 ug/mL EthambutolcellWall

-0.199

Eta12-40 ug/mL EthionamidecellWall

-0.038

INH0.2-0.4 ug/mL IsoniazidcellWall

0.187

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.479

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.566

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.435

BZA0.12 mg/mL BenzamidearomaticAmides

-0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.149

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.233

H2O24 mM hydrogen peroxideDNAdamaging

0.329

Levo10 ug/mL LevofloxacinDNAdamaging

-0.402

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.353

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.327

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.129

UVUV-irradiationDNAdamaging

-0.188

ARP41-4 ug/mL Antitubercular compound ARP4?

0.525

Antimycin12.5-50 ug/mL Antimycin A?

-0.194

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.309

PA_110-50 ug/mL Antitubercular compound PA-1?

0.534

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.278

PA8240.2-2 ug/mL PA-824?

0.777

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.066

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.708

Verapamil50 uM Verapamil?

-0.904

mercaptoethanol2 mM 2-Mercaptoethanol?

0.436

methoxatin10-20 ug/mL Methoxatin?